Thrivent Financial for Lutherans Trims Holdings in Agilent Technologies, Inc. $A

Thrivent Financial for Lutherans reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 11.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 265,967 shares of the medical research company’s stock after selling 35,337 shares during the period. Thrivent Financial for Lutherans owned 0.09% of Agilent Technologies worth $31,320,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Resona Asset Management Co. Ltd. increased its stake in Agilent Technologies by 6.2% in the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after purchasing an additional 5,767 shares during the last quarter. TrueMark Investments LLC acquired a new stake in Agilent Technologies in the 2nd quarter worth about $1,999,000. Nuance Investments LLC boosted its stake in Agilent Technologies by 13.5% in the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after buying an additional 9,628 shares during the last quarter. Fenimore Asset Management Inc increased its stake in shares of Agilent Technologies by 2.7% during the 2nd quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock valued at $21,346,000 after acquiring an additional 4,823 shares during the last quarter. Finally, Godsey & Gibb Inc. increased its stake in shares of Agilent Technologies by 19.8% during the 2nd quarter. Godsey & Gibb Inc. now owns 166,664 shares of the medical research company’s stock valued at $19,668,000 after acquiring an additional 27,520 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Insiders Place Their Bets

In related news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 16,401 shares of company stock valued at $2,468,962. Company insiders own 0.26% of the company’s stock.

Agilent Technologies Price Performance

Shares of NYSE A opened at $140.62 on Tuesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27. The company has a market capitalization of $39.86 billion, a price-to-earnings ratio of 30.77, a PEG ratio of 4.05 and a beta of 1.27. The business has a 50-day moving average of $145.57 and a 200-day moving average of $129.47.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company’s revenue was up 9.4% on a year-over-year basis. During the same period last year, the business posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s payout ratio is currently 22.32%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on A. Bank of America boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Wells Fargo & Company boosted their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. increased their target price on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $161.77.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.